Supporting this observation is that IMP-1088 and DDD85646 inhibit potently both human and protozoan NMTs [16,17], and therefore, using these compounds to treat infectious diseases may cause unintended toxicity by inhibiting the human NMT enzymes. The gene discussed is NMT1; the disease is infectious disease.